US 7666889
Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes
granted A61PA61P1/04A61P1/16
Quick answer
US patent 7666889 (Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes) held by Jenrin Discovery, LLC expires Mon Feb 18 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Jenrin Discovery, LLC
- Grant date
- Tue Feb 23 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 18 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 11
- CPC classes
- A61P, A61P1/04, A61P1/16, A61P11/00, A61P13/08